University of North Dakota
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of North Dakota
A women’s health care company in turnaround – one well recognized for assessing a woman’s risk of developing breast cancer through the HALO breast test – is developing a breast cancer diagnostic based on the presence of three protein biomarkers found in breast nipple aspirate fluid. The HALO Pivot diagnostic kit from Halo Healthcare Inc. is an in-office, noninvasive test for diagnosing cancer or a recurrence at a very early stage.
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.